Alfa Rhythm

Electro-biometric Stimulator for Depression, Anxiety, and Sleep Disorders

Health Tech & Life Sciences
Acquired by Generex Biotechnology on Oct 2015
Follow

Company Overview

Snapshot

Founded in February 2014 by Khaled Khalil, Alfa Rhythm is a Health Tech & Life Sciences company with 1–10 employees. The company was acquired by Generex Biotechnology in October 2015.

Business overview

Alfa Rhythm develops a unique electro-biometric stimulator designed to balance brain frequencies. Its core technology uses externally based, frequency-programmed vibrations to generate waveforms that aid in regulating and synchronizing brainwave activity. The company's device, the Alfa Watch, is intended to treat complications associated with ADD/ADHD, stress, depression, anxiety, headaches, insomnia, Alzheimer’s, Parkinson’s, and epilepsy through a natural, non-invasive, and external treatment approach. Alfa Rhythm operates within the Digital Health and Medical Technologies sector, serving patients in the healthcare market.

Strategic signal

In October 2015, Alfa Rhythm was acquired by Generex Biotechnology, signaling a strategic integration of its electro-biometric stimulation technology into a larger corporate framework. This acquisition highlights the potential for Alfa Rhythm's non-invasive brain stimulation device to be further developed and commercialized under the umbrella of a multinational company, potentially expanding its reach and application in treating various neurological and mental health conditions.

Log in to access full profile

Company Intelligence Q&A

What is Alfa Rhythm's primary product?
Alfa Rhythm's primary product is the Alfa Watch, an electro-biometric stimulator designed to balance brain frequencies and aid in changing brainwaves.
When was Alfa Rhythm founded?
Alfa Rhythm was founded in February 2014.
What conditions does Alfa Rhythm's technology aim to treat?
Alfa Rhythm's devices are made to treat complications with ADD/ADHD, stress, depression, anxiety, headaches, insomnia, Alzheimer’s, Parkinson’s, and epilepsy.
Who acquired Alfa Rhythm?
Alfa Rhythm was acquired by Generex Biotechnology in October 2015.
Who is a co-founder of Alfa Rhythm?
Khaled Khalil is a co-founder of Alfa Rhythm, also serving as EVP R&D and Chairman.
Log in to access full profile